Showing results (171-180 of 189) with videos related to
Sort By:
Pageof 19
Cancer Biology & Therapy|June 22, 2026
CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of Nras G12D-driven chronic myelomonocytic leukemiaYuchen Li, Xu Jiang, Yinfeng Gu, et al.Biochemical and Biophysical Research Communications|October 29, 2011
An oligodeoxynucleotide capable of lessening acute lung inflammatory injury in mice infected by influenza virusMingli Fang, Min Wan, Sheng Guo, et al.European Journal of Medical Research|November 12, 2014
Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemiaYu Ma, Ziwei Liao, Yi Xu, et al.European Journal of Medicinal Chemistry|January 7, 2025
Design, synthesis, and biological evaluation of a potent and orally bioavailable FGFRs inhibitor for fibrotic treatmentLin Yue, Zui Tan, Wei Wei, et al.European Journal of Immunology|April 19, 2006
Heat shock fusion protein induces both specific and nonspecific anti-tumor immunityDapeng Li, Hui Li, Peiyin Zhang, et al.Clinical Immunology (Orlando, Fla.)|November 22, 2005
Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotideMusheng Bao, Yi Zhang, Min Wan, et al.Biochemical Pharmacology|August 30, 2019
Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathwayYongxia Zhu, Weiqiong Zuo, Lijuan Chen, et al.Frontiers in Oncology|January 2, 2023
Increased PD-1+Foxp3+ γδ T cells associate with poor overall survival for patients with acute myeloid leukemiaJiamian Zheng, Dan Qiu, Xuan Jiang, et al.Journal of Medicinal Chemistry|February 19, 2021
Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2Zhihao Liu, Xi Hu, Qiwei Wang, et al.Cancer Cell International|May 3, 2014
Abnormal expression of A20 and its regulated genes in peripheral blood from patients with lymphomasXu Wang, Yan Xu, Lichan Liang, et al.Pageof 19